Pennant Investors, Lp Top Holdings and 13F Report (2024) → Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (From Paradigm Press) (Ad) About Pennant Investors, LpInvestment ActivityPennant Investors, Lp has $403.67 million in total holdings as of March 31, 2024.Pennant Investors, Lp owns shares of 44 different stocks, but just 8 companies or ETFs make up 80% of its holdings.Approximately 7.88% of the portfolio was purchased this quarter.About 30.77% of the portfolio was sold this quarter.This quarter, Pennant Investors, Lp has purchased 43 new stocks and bought additional shares in 1 stock.Pennant Investors, Lp sold shares of 4 stocks and completely divested from 1 stock this quarter.Largest Holdings Amazon.com $53,392,480TransDigm Group $51,727,200Antero Resources $47,357,000Microsoft $47,120,640Micron Technology $36,074,340 Largest New Holdings this Quarter Enovis $24,980,000 HoldingTRAVERE THERAPEUTICS INC $430,218 Holding Largest Purchases this Quarter Enovis 400,000 shares (about $24.98M)Antero Resources 220,000 shares (about $6.38M)TRAVERE THERAPEUTICS INC 55,800 shares (about $430.22K) Largest Sales this Quarter Apple 470,000 shares (about $80.60M)Alphabet 176,000 shares (about $26.56M)Amazon.com 52,000 shares (about $9.38M)Microsoft 17,000 shares (about $7.15M) Sector Allocation Over TimeMap of 500 Largest Holdings ofPennant Investors, Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorAMZNAmazon.com$53,392,480$9,379,760 ▼-14.9%296,00013.2%Retail/WholesaleTDGTransDigm Group$51,727,2000.0%42,00012.8%AerospaceARAntero Resources$47,357,000$6,380,000 ▲15.6%1,633,00011.7%Oils/EnergyMSFTMicrosoft$47,120,640$7,152,240 ▼-13.2%112,00011.7%Computer and TechnologyMUMicron Technology$36,074,3400.0%306,0008.9%Computer and TechnologySATSEchoStar$30,683,2280.0%2,153,2097.6%Computer and TechnologyGOOGLAlphabet$30,035,070$26,563,680 ▼-46.9%199,0007.4%Computer and TechnologyAAPLApple$27,436,800$80,595,600 ▼-74.6%160,0006.8%Computer and TechnologyENOVEnovis$24,980,000$24,980,000 ▲New Holding400,0006.2%MedicalODPODP$21,220,0000.0%400,0005.3%Retail/WholesalePRMPerimeter Solutions$17,066,0000.0%2,300,0004.2%Basic MaterialsFGENFibroGen$1,805,7400.0%768,4000.4%MedicalARQTArcutis Biotherapeutics$1,693,6190.0%170,9000.4%MedicalALTAltimmune$1,117,7640.0%109,8000.3%MedicalFATEFate Therapeutics$1,072,3740.0%146,1000.3%MedicalNRIXNurix Therapeutics$834,9600.0%56,8000.2%MedicalMGNXMacroGenics$644,7360.0%43,8000.2%MedicalIGMSIGM Biosciences$626,2850.0%64,9000.2%MedicalENTAEnanta Pharmaceuticals$612,8460.0%35,1000.2%MedicalALLOAllogene Therapeutics$573,9480.0%128,4000.1%MedicalETNB89bio$517,9800.0%44,5000.1%MedicalZNTLZentalis Pharmaceuticals$510,6240.0%32,4000.1%MedicalRCUSArcus Biosciences$447,4560.0%23,7000.1%MedicalARCTArcturus Therapeutics$442,3870.0%13,1000.1%MedicalAGIOAgios Pharmaceuticals$441,5240.0%15,1000.1%MedicalTRAVERE THERAPEUTICS INC$430,218$430,218 ▲New Holding55,8000.1%NOTE 2.500% 9/1GETRGetaround$413,8830.0%1,348,1530.1%Business ServicesZYMEZymeworks$407,1240.0%38,7000.1%MedicalCHRSCoherus BioSciences$401,7590.0%168,1000.1%MedicalCMPXCompass Therapeutics$394,0200.0%199,0000.1%MedicalRLAYRelay Therapeutics$351,9200.0%42,4000.1%MedicalERASErasca$342,3720.0%166,2000.1%MedicalSAGESage Therapeutics$327,9500.0%17,5000.1%MedicalNVAXNovavax$288,2340.0%60,3000.1%MedicalAGENAgenus$272,3680.0%469,6000.1%MedicalQUREuniQure$252,2000.0%48,5000.1%MedicalREPLReplimune Group$249,1850.0%30,5000.1%MedicalBTAIBioXcel Therapeutics$236,5980.0%83,9000.1%MedicalALLKAllakos$234,4860.0%186,1000.1%MedicalMCRBSeres Therapeutics$226,2690.0%292,3000.1%MedicalALVRAlloVir$162,8320.0%215,7000.0%MedicalMIMOAirspan Networks$118,3640.0%1,047,4730.0%Computer and TechnologyBLUEbluebird bio$111,8720.0%87,4000.0%MedicalGRABWGrab$16,2080.0%80,0000.0%Computer and TechnologyTVTXTravere Therapeutics$0$501,642 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data: SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.